Heightened resistance to type 1 interferons characterizes HIV-1 at transmission and following analytical treatment interruption (2020)
Attributed to:
Design of HIV vaccines that stimulate T cell and NK cell immunity
funded by
MRC
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1101/2020.08.24.20181149
Publication URI: http://dx.doi.org/10.1101/2020.08.24.20181149
Type: Preprint